Assignee
TARSUS PHARMACEUTICALS INC
US·10 granted patents·10 pending applications·45 citations·filing 2018–2025
Top patents by PatentIndex Score
20 records- 0198US11197847B2Isoxazoline parasiticide formulations and methods for treating blepharitisTARSUS PHARMACEUTICALS INC·Filed 2021·Granted Dec 14, 2021·11 cites·23 claims
- 0297US11690826B2Methods for treating demodex blepharitis using lotilaner formulationsTARSUS PHARMACEUTICALS INC·Filed 2022·Granted Jul 4, 2023·6 cites·20 claims
- 0397US11690827B2Methods for treating ocular Demodex using lotilaner formulationsTARSUS PHARMACEUTICALS INC·Filed 2022·Granted Jul 4, 2023·6 cites·20 claims
- 0496US12364685B2Isoxazoline parasiticide formulationsTARSUS PHARMACEUTICALS INC·Filed 2024·Granted Jul 22, 2025·1 cites·32 claims
- 0596US12213964B2Isoxazoline parasiticide formulationsTARSUS PHARMACEUTICALS INC·Filed 2023·Granted Feb 4, 2025·2 cites·21 claims
- 0696US12171750B2Isoxazoline parasiticide formulations and methods for treating blepharitisTARSUS PHARMACEUTICALS INC·Filed 2023·Granted Dec 24, 2024·2 cites·16 claims
- 0796US11752137B2Ophthalmic compositions for treating ocular Demodex using lotilaner formulationsTARSUS PHARMACEUTICALS INC·Filed 2022·Granted Sep 12, 2023·4 cites·20 claims
- 0895US10835517B2Methods for treating ocular demodex using isoxazoline parasiticide formulationsTARSUS PHARMACEUTICALS INC·Filed 2018·Granted Nov 17, 2020·12 cites·28 claims
- 0991US2025127762A1Isoxazoline parasiticide formulations and methods for treating blepharitisTARSUS PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1088US2025312317A1Isoxazoline parasiticide formulations and methods for treating blepharitisTARSUS PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 1188US2025312318A1Isoxazoline parasiticide formulations and methods for treating blepharitisTARSUS PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 1286US2023190711A1Methods for treating ocular demodex using spinosad formulationsTARSUS PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1376US2021077465A1Isoxazoline parasiticide formulations and methods for treating blepharitisTARSUS PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1476US2022054457A2Methods for treating ocular demodex using spinosad formulationsTARSUS PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1574US12257263B2Pharmaceutical compositions for demodex related blepharitis and eyelid crustingTARSUS PHARMACEUTICALS INC·Filed 2022·Granted Mar 25, 2025·1 cites·7 claims
- 1671US2023218584A1Systemic isoxazoline parasiticides for vector-borne and viral disease treatment or prophylaxisTARSUS PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1759US2025213602A1Pharmaceutical compositions for demodex related blepharitis and eyelid crustingTARSUS PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 1856US2022160682A1Systemic isoxazoline parasiticides for vector-borne and viral disease treatment or prophylaxisTARSUS PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1955US12502377B2Method of eradicating ticks that attach to humans using lotilaner formulationsTARSUS PHARMACEUTICALS INC·Filed 2025·Granted Dec 23, 2025·0 cites·29 claims
- 2053US2022249445A1Isoxazoline parasiticide formulations and methods for treating blepharitisTARSUS PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →